| Report ID | 280899 |
| Drug Identification Number | 02357208 |
| Brand name | JAMP-AMLODIPINE |
| Common or Proper name | Amlodipine Besylate Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | AMLODIPINE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | C08CA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2026-03-12 |
| Estimated end date | 2026-04-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-27 |
| Company comments | Allocation, other format available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2026-03-27 | French | Compare |
| v7 | 2026-03-27 | English | Compare |
| v6 | 2026-03-20 | French | Compare |
| v5 | 2026-03-20 | English | Compare |
| v4 | 2026-03-20 | French | Compare |
| v3 | 2026-03-20 | English | Compare |
| v2 | 2026-03-20 | French | Compare |
| v1 | 2026-03-20 | English | Compare |
Showing 1 to 8 of 8